Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
4.890
+0.110 (2.30%)
At close: Oct 9, 2025, 4:00 PM EDT
4.875
-0.015 (-0.31%)
After-hours: Oct 9, 2025, 4:04 PM EDT
AVR Market Cap
AVR has a market cap or net worth of $166.35 million as of October 9, 2025. Its market cap has decreased by -6.96% in one year.
Market Cap
166.35M
Enterprise Value
140.36M
1-Year Change
-6.96%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $166.35M, an increase of 234.89%. That is a compound annual growth rate of 16.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 166.35M | -9.56% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | 16.71M | -59.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |